Healthy Extracts (HYEX) Stock Price, News & Analysis

Healthy Extracts Inc. (OTCQB: HYEX) is a Nevada-based healthcare company that focuses on plant-based, science-based nutraceuticals for brain, heart, gut and metabolic health. Operating in the healthcare sector and aligned with the drug manufacturers and specialty nutraceutical space, the company develops, manufactures and markets proprietary supplement formulations and novel oral delivery technologies designed to support transformational health and longevity.

Business model and platform

Healthy Extracts describes itself as a platform for acquiring, developing, manufacturing, patenting, marketing and distributing plant-based nutraceuticals. According to company disclosures and press releases, this platform combines clinically tested formulas, exclusive partnerships and intellectual property around delivery systems. The company emphasizes subscription-based direct-to-consumer sales, retail distribution, and white-label and private-label manufacturing relationships as key commercial channels for its products and technologies.

The company’s growth strategy, as outlined in multiple news releases, centers on:

• Developing proprietary, clinically formulated supplements for brain, heart, gut and metabolic health.
• Expanding recurring revenue through direct-to-consumer subscriptions and Amazon "Subscribe & Save" programs.
• Acquiring and integrating complementary businesses and technologies, such as Gummy USA.
• Leveraging exclusive oral delivery systems to differentiate products and open new distribution channels.

Key subsidiaries and brands

Healthy Extracts operates through several wholly owned subsidiaries and brand platforms:

• BergametNA™ – Heart health-focused nutraceutical business. Company materials state that BergametNA offers natural heart health supplements and that its products are the only heart health supplements distributed in North America containing Citrus Bergamot SuperFruit™, described as a superfruit with the highest known concentration of polyphenols and flavonoids.
• Ultimate Brain Nutrients™ (UBN) – Brain health and performance unit offering nutraceutical formulations for cognitive support. UBN’s KETONOMICS® formulations are described as designed to enhance brain activity, focus, headache and cognitive behavior, and provide opportunities for sales and IP licensing.
• Gummy USA™ – A wholly owned subsidiary following a merger and acquisition structure detailed in SEC filings and press releases. Gummy USA is characterized as a leading developer and advanced manufacturer of precision-dosed nutraceutical and pharmaceutical-grade gummies, operating a HACCP, GMP-certified and FDA-registered manufacturing facility in Florida. Its proprietary, patent-pending SureDose™ technology is promoted as delivering superior safety, efficacy and compliance for white-label and private-label customers.

Oral delivery technologies

A distinctive feature of Healthy Extracts is its focus on exclusive oral delivery systems that aim to improve convenience, bioavailability and user experience. Based on company communications, these include:

• Gelteq gel-packs – Gel-based delivery system licensed from Gelteq Ltd. Healthy Extracts has an exclusive North American storage, shipping and fulfillment partnership for certain Gelteq products. The technology underpins on-the-go gel-pack products such as Hydrate EZ™ and Mynus Sugar™, which are designed for rapid hydration and support of healthy carbohydrate metabolism, respectively.
• Functional fiber drinking straws – Nutrient-infused straws developed through an exclusive joint product development agreement with Lelantos Fibre. An example is the WHITNEY JOHNS™ Gut Health Straw™, described as a fiber pre- and probiotic delivery straw targeting digestive health, allowing users to consume a prebiotic and probiotic blend simply by sipping through the straw.
• Precision-dosed gummies – Through Gummy USA and its SureDose technology, Healthy Extracts offers precision-dosed gummies for nutraceutical and pharmaceutical-grade applications, serving both its own brands and white-label/private-label clients.

Representative products and health focus areas

Company news releases highlight several flagship and newer products that illustrate Healthy Extracts’ focus areas:

• STAT10 – A heart health formulation under BergametNA that contains CoQ10, Berberine and Citrus Bergamot SuperFruit™. It is described as clinically formulated to support nutrients inhibited by statins and to address common side effects such as muscle and joint pain, weakness and tiredness often associated with statin use.
• 4Sleep – A natural, science-based sleep formulation designed to support deeper, more restorative rest.
• Hydrate EZ™ – An on-the-go gel-pack product featuring Gelteq’s technology, formulated to deliver rapid hydration and essential electrolytes in a no-mix, no-mess format without sugar or caffeine.
• Mynus Sugar™ – A gel-pack supplement clinically formulated to support healthy post-meal carbohydrate metabolism and designed to reduce the amount of sugar absorbed into the bloodstream after eating carbohydrates.
• Whitney Johns Gut Health Straw™ – A private-label product for Whitney Johns Nutrition using Healthy Extracts’ exclusive functional drinking straw technology, targeting gut health with a prebiotic and probiotic blend.

Across these offerings, Healthy Extracts emphasizes science-based formulations, clinical research support, and partnerships with healthcare professionals and influencers. For certain private-label gummy products, formulations are described as developed under the guidance of doctors, clinical professors and healthcare professionals.

Gummy USA acquisition and integration

According to an 8-K filing and related press releases, Healthy Extracts completed a transaction to acquire Gummy USA LLC, initially through a membership interest purchase agreement and subsequently via an Agreement and Plan of Merger under which Gummy USA was merged into a wholly owned subsidiary, HE Gummy USA, Inc. As consideration, the company issued common stock representing a majority of its outstanding shares to Gummy USA’s founder, Donald Swanson, who was granted anti-dilution rights tied to existing options and warrants.

The acquisition brought in-house a HACCP, GMP-certified and FDA-registered manufacturing facility with state-of-the-art equipment and in-house R&D. Company statements indicate that this vertical integration is intended to accelerate product development, strengthen intellectual property, enhance margins, and support projected production capacity that management believes could scale to a substantial annual revenue level.

Revenue model and channels

Healthy Extracts’ revenue model, as described in its news flow, combines:

• Direct-to-consumer subscriptions for its branded nutraceutical products, including subscription programs on its own websites.
• Amazon "Subscribe & Save" and other e-commerce channels, where the company has reported maintaining a top-three ranking in its category on Amazon.com for certain heart and brain health products.
• Retail and physical distribution, including expansion into new retail channels and potential placements in fitness and elderly care centers and healthcare provider networks, particularly for newer delivery formats like gummies and straws.
• White-label and private-label manufacturing through Gummy USA, serving premium brands and distributors with precision-dosed nutraceutical gummies tailored to specific health needs, such as women’s hormonal balance.

Company communications repeatedly highlight the importance of subscription-based recurring revenue and multi-channel distribution in driving growth, cash flow and customer lifetime value.

Corporate structure and governance notes

Healthy Extracts Inc. is incorporated in Nevada and files periodic reports with the U.S. Securities and Exchange Commission under Commission File Number 000-55572. An 8-K dated October 2, 2025, describes the acquisition and merger steps involving Gummy USA, the issuance of common stock to Donald Swanson, and associated changes in control and board composition. The filing notes that Swanson was appointed as a director, Chairman and Chief Executive Officer, with Kevin “Duke” Pitts serving as President and Chief Operating Officer, and that anti-dilution rights were granted to maintain Swanson’s ownership percentage in the event of option and warrant exercises.

Positioning within the healthcare and nutraceutical sector

Within the broader healthcare sector and drug manufacturers–specialty and generic category, Healthy Extracts positions itself as a research-based nutraceutical and oral delivery technology company. Rather than focusing on conventional pharmaceuticals, it concentrates on plant-based supplements and functional products aimed at heart, brain, gut and metabolic health, supported by clinical research, proprietary formulations and branded ingredients like Citrus Bergamot SuperFruit™.

The company’s emphasis on delivery innovation—including gel-packs, functional fiber straws and precision-dosed gummies—addresses consumer preferences for alternatives to traditional pills and capsules. Company materials also reference demand from individuals who experience “pill fatigue” or difficulty swallowing pills, and from younger consumers who prefer alternative formats.

Investor considerations

Healthy Extracts is described in conference invitations and media coverage as a microcap nutraceutical technology company. It has presented at investor-focused events such as the ArcStone-Kingswood Growth Summit and the Trickle Research Microcap Conference, where management has highlighted record net revenue trends, recurring subscription growth, and the impact of the Gummy USA merger on its growth outlook.

For investors researching HYEX stock, key themes in company communications include:

• Focus on science-based, plant-derived nutraceuticals for heart, brain, gut and metabolic health.
• Integration of exclusive oral delivery systems and proprietary manufacturing technologies.
• Use of subscriptions and e-commerce to build recurring revenue streams.
• Growth through acquisitions and strategic partnerships in the nutraceutical and delivery-technology space.